Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.03644
0.00 (0.00%)
May 26, 2026, 9:30 AM EST

RMTG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5.14.112.411.530.44
Revenue Growth (YoY)
24.17%70.44%57.49%249.46%694.97%
Cost of Revenue
2.291.280.730.650.29
Gross Profit
2.812.821.680.880.15
Selling, General & Admin
3.322.472.071.729.93
Operating Expenses
3.62.692.381.879.97
Operating Income
-0.790.13-0.71-0.99-9.82
Interest Expense
-7.45-5.64-6.49-4.4-2.72
Other Non Operating Income (Expenses)
0.84-0.05-0-0.18-0.1
EBT Excluding Unusual Items
-7.4-5.56-7.2-5.58-12.64
Impairment of Goodwill
---4.13--
Legal Settlements
-----0.23
Other Unusual Items
-0.42-1.51--
Pretax Income
-7.81-5.56-9.81-5.58-12.87
Earnings From Continuing Operations
-7.81-5.56-9.81-5.58-12.87
Earnings From Discontinued Operations
---0.07-0.01
Net Income
-7.81-5.56-9.81-5.51-12.88
Net Income to Common
-7.81-5.56-9.81-5.51-12.88
Shares Outstanding (Basic)
1313121211
Shares Outstanding (Diluted)
1313121211
Shares Change (YoY)
0.82%0.68%1.86%6.42%22.91%
EPS (Basic)
-0.62-0.44-0.79-0.45-1.12
EPS (Diluted)
-0.62-0.44-0.79-0.45-1.12
Free Cash Flow
-1.310.64-0.8-1.31-9.88
Free Cash Flow Per Share
-0.100.05-0.07-0.11-0.86
Gross Margin
55.11%68.73%69.53%57.31%34.29%
Operating Margin
-15.43%3.25%-29.30%-64.99%-2242.37%
Profit Margin
-153.17%-135.44%-407.21%-359.87%-2942.42%
Free Cash Flow Margin
-25.67%15.47%-33.40%-85.78%-2255.99%
EBITDA
-0.510.35-0.4-0.84-9.78
EBITDA Margin
-9.92%8.62%-16.44%-55.01%-
D&A For EBITDA
0.280.220.310.150.04
EBIT
-0.790.13-0.71-0.99-9.82
EBIT Margin
-15.43%3.25%-29.30%-64.99%-
Advertising Expenses
0.720.460.480.320.13
Source: S&P Global Market Intelligence. Standard template. Financial Sources.